2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9978):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-D0875S
    PIPES-d18
    PIPES-d18 is the deuterium labeled PIPES. PIPES (1,4-Piperazinediethanesulfonic acid) is an important component of PIPES buffer agent used in biochemistry.
    PIPES-d<sub>18</sub>
  • HY-N0593S2
    Deoxycholic acid-d6
    Deoxycholic acid-d6 is the deuterium labeled Deoxycholic acid. Deoxycholic acid is specifically responsible for activating the G protein-coupled bile acid receptor TGR5 that stimulates brown adipose tissue (BAT) thermogenic activity.
    Deoxycholic acid-d<sub>6</sub>
  • HY-W099613S1
    1-Bromodecane-d3
    1-Bromodecane-d3 is the deuterium labeled 1-Bromodecane.
    1-Bromodecane-d<sub>3</sub>
  • HY-W743804
    Aclidinium-d5 bromide
    Aclidinium-d5 (LAS 34273-d5; LAS-W 330-d5) bromide is deuterium-labeled Aclidinium Bromide (HY-14144).
    Aclidinium-d<sub>5</sub> bromide
  • HY-B0946S1
    Sulfamonomethoxine-d3
    Sulfamonomethoxine-d3 is the deuterium labeled Sulfamonomethoxine (HY-B0946). Sulfamonomethoxine is an orally active sulfonamide antibiotic for veterinary use. Sulfamonomethoxine is also an inhibitor of dihydropteroate synthetase, which can block the synthesis of folic acid. Sulfamonomethoxine has antibacterial activity.
    Sulfamonomethoxine-d<sub>3</sub>
  • HY-W001955S
    2-(4-Fluorophenyl)acetic acid-d2
    2-(4-Fluorophenyl)acetic acid-d2 is the deuterium labeled 2-(4-Fluorophenyl)acetic acid.
    2-(4-Fluorophenyl)acetic acid-d<sub>2</sub>
  • HY-W251703S
    (2-Hydroxyethyl)phosphonic acid-d4
    (2-Hydroxyethyl)phosphonic acid-d4 (2-Hydroxyethanephosphonic Acid-d4) is the deuterium labeled (2-Hydroxyethyl)phosphonic acid (HY-W251703).
    (2-Hydroxyethyl)phosphonic acid-d<sub>4</sub>
  • HY-135582S
    Raloxifene 4'-glucuronide-d4
    Raloxifene 4'-glucuronide-d4 is deuterated labeled Raloxifene 4'-glucuronide (HY-135582). Raloxifene 4'-glucuronide is a primary metabolite of Raloxifene. Raloxifene 4'-glucuronide formation is mediated mostly by UGT1A10 and UGT1A8. Raloxifene 4'-glucuronide binds to estrogen receptor with an IC50 of 370 μM. . Raloxifene is a selective estrogen receptor modulator. Raloxifene activates TGFβ3 promoter as a full agonist at nanomolar concentrations, and inhibits the estrogen response element-containing vitellogenin promoter expression.
    Raloxifene 4'-glucuronide-d<sub>4</sub>
  • HY-W765014
    Tolylfluanide-d7
    Tolylfluanide-d7 is the deuterium labeled Tolylfluanid (HY-W774955).
    Tolylfluanide-d<sub>7</sub>
  • HY-W743198
    Adenosine N1-oxide-15N
    Adenosine N1-oxide-15N is the 15N-labeled Adenosine N1-oxide (HY-102082). Adenosine N1-oxide is an oral active anti-inflammatory agent, and can be isolated from royal jelly. Adenosine N1-oxide promotes osteogenic and adipocyte differentiation.
    Adenosine N1-oxide-<sup>15</sup>N
  • HY-W099613S3
    1-Bromodecane-d4
    1-Bromodecane-d4 is the deuterium labeled 1-Bromodecane.
    1-Bromodecane-d<sub>4</sub>
  • HY-114041S1
    Resolvin E1-d4-1
    Resolvin E1-d4-1 is the deuterium labeled Resolvin E1. Resolvin E1 (RvE1), a potent endogenous pro-resolving mediator of inflammation, is derived from omega-3 fatty acid eicosapentaenoic acid (EPA). Resolvin E1 is endogenously biosynthesized from EPA in the presence of Aspirin during the spontaneous resolution phase of acute inflammation, where specific cell-cell interactions occur. Resolvin E1 possesses unique counterregulatory actions that inhibit polymorphonuclear leukocyte (PMN) transendothelial migration. Resolvin E1 also acts as a potent inhibitor of leukocyte infiltration, dendritic cell migration, and IL-12 production.
    Resolvin E1-d<sub>4</sub>-1
  • HY-11101S
    Alendronate-d6 sodium hydrate
    Alendronate-d6 sodium hydrate is deuterated labeled Alendronate sodium hydrate (HY-11101). Alendronate sodium hydrate is a farnesyl diphosphate synthase inhibitor with IC50 of 460 nM.
    Alendronate-d<sub>6</sub> sodium hydrate
  • HY-W011340S
    5-Hydroxy flunixin-d3 (Major)
    5-Hydroxy flunixin-d3 (Major) is the deuterium labeled 5-Hydroxy flunixin (Major).
    5-Hydroxy flunixin-d<sub>3</sub> (Major)
  • HY-W008371S2
    Fmoc-Met-OH-d3
    Fmoc-Met-OH-d3 is the deuterium labeled Fmoc-Met-OH.
    Fmoc-Met-OH-d<sub>3</sub>
  • HY-W020772AS
    Aminoguanidine-13C,15N2 sulfate (1:2)
    Aminoguanidine-13C,15N2 sulfate (1:2) is the 13C, 15N labeled Aminoguanidine sulfate (1:2).
    Aminoguanidine-<sup>13</sup>C,<sup>15</sup>N<sub>2</sub> sulfate (1:2)
  • HY-145003S
    4(Z),7(Z)-Decadienoic acid-d5
    4(Z),7(Z)-Decadienoic acid-d5 is the deuterium labeled 4(Z),7(Z)-Decadienoic acid.
    4(Z),7(Z)-Decadienoic acid-d<sub>5</sub>
  • HY-12769S
    Mebeverine acid-d5
    Mebeverine acid-d5 (Mebeverine metabolite Mebeverine acid-d5) is the deuterium labeled Mebeverine Acid (HY-12769). Mebeverine acid is a secondary metabolite of the intestinal antispasmodic agent Mebeverine (HY-A0078). Mebeverine acid is generated by the hydrolysis of Mebeverine in the body and is considered a key circulating metabolite. Mebeverine acid is an important marker for oral Mebeverine.
    Mebeverine acid-d<sub>5</sub>
  • HY-W654268
    3-Methylphosphinicopropionic Acid-d3 Sodium Salt
    3-Methylphosphinicopropionic Acid-d3 Sodium Salt is the deuterium labeled Sodium 3-(methyloxidophosphoryl)propanoate (HY-W702114).
    3-Methylphosphinicopropionic Acid-d<sub>3</sub> Sodium Salt
  • HY-W753207
    Porphobilinogen-13C2,15N
    Porphobilinogen-13C2,15N is the 13C- and 15N-labeled Porphobilinogen (HY-W013495). Porphobilinogen could act as a phototoxin, a neurotoxin, and a metabotoxin.
    Porphobilinogen-<sup>13</sup>C<sub>2</sub>,<sup>15</sup>N